References
- Briggs G G, Freeman R K, Yaffe S J. Drugs in pregnancy and lactation. Lippincott Williams and Wilkins, Philadelphia, PA 2002
- Nordeng H, Lindemann R, Perminov K V, Reikvam A. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001; 90: 288–291
- Haddad P M, Pal B R, Clarke P, Wieck A, Sridhiran S. Neonatal symptoms following maternal paroxetine treatment: Serotonin toxicity or paroxetine discontinuation syndrome. J Psychopharmacol 2005; 19: 554–557
- Chambers C D, Johnson K A, Dick L M, Felix R J, Jones K L. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335: 1010–1015
- Hegerl U, Bottlender R, Gallinat J, Kuss H J, Ackenheil M, Moller H J. The serotonin syndrome scale: First results on validity. Eur Arch Psychiatry Clin Neurosci 1998; 248: 96–103
- Laegreid L, Olegard R, Walstrom J, Conradi N. Teratogenic effects of benzodiazepine use during pregnancy. J Pediatr 1989; 114: 126–131